Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Alexandria Real Estate Equities, Inc. ARE

Real Estate — Reit Office
S&P 500 Member Insider Buys (last 12m)
Indexes indicate stock being part of an index ,
Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total buys
3.19
Total sells
1.90
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — 1 — 1 — 1 3 — — 1 1
Sell — — 1 — 1 — 1 — 1 — 1 1
Insider Ownership
0.37%

Capital & Financial Ratios

Market Cap
9,780.00
Revenue
2,840.16
Net Income
(833.79)
Free Cash Flow
1,716.83
Net Debt
12,337.73
Current Ratio
0.19
Debt/Equity
0.67
P/E ratio
0.00
P/S ratio
3.39
P/B ratio
0.50
Past 5Y EPS Growth
(10.42%)
This Y EPS Growth
117.96%
Next Y EPS Growth
(160.58%)
Next 5Y EPS Growth
51.99%
in millions of $

Dividends

Payout Ratio
1.43
Annual Dividend Rate
4.96
Annual Dividend Yield
4.37%
total individual payouts
2026 2.16
—
—
—
2025 4.68
—
—
—
—
2024 5.19
—
—
—
—
2023 4.96
—
—
—
—
2022 4.72
—
—
—
—
2021 4.48
—
—
—
—
2020 4.24
—
—
—
—
2019 4.00
—
—
—
—
2018 3.73
—
—
—
—
2017 3.45
—
—
—
—
2016 3.23
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 660.77 559.85 553.76 475.14
Receivables 8.21 6.41 6.67 7.66
Inventory — — — —
Other — — — —
668.98 566.26 560.43 482.80
2023 2024 2025 Q'26
Payables 2,610.94 2,654.35 2,397.07 2,513.53
ST’ Debt — — — —
Other — — — —
2,610.94 2,654.35 2,397.07 2,513.53
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡ ‡‡‡ ‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 671.02 662.78 — —
—
’25 758.16 762.04 751.94 754.41
3,026.56
’24 769.11 766.73 791.61 788.95
3,116.39
’23 700.80 713.90 713.79 757.22
2,885.70
’22 615.07 643.76 659.85 670.28
2,588.96
’21 479.85 509.62 547.76 576.92
2,114.15
’20 439.92 436.96 545.04 463.72
1,885.64
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 196.62 336.97 — —
—
’25 207.95 460.24 433.48 312.38
1,414.05
’24 341.16 411.80 477.39 274.18
1,504.52
’23 305.57 478.47 417.89 428.62
1,630.55
’22 191.09 339.03 363.04 401.16
1,294.32
’21 212.05 239.76 308.82 249.56
1,010.20
’20 191.27 202.39 315.28 173.57
882.51
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (349.37) (61.58) — —
—
’25 (369.71) 105.92 53.95 2,073.84
1,864.00
’24 (529.44) (143.20) (0.62) 726.67
53.41
’23 (745.34) 76.45 (226.19) 37.33
(857.75)
’22 (2,379.08) (275.71) (281.51) (960.22)
(3,896.52)
’21 (2,098.71) (1,373.24) (1,003.09) (1,848.70)
(6,323.73)
’20 (664.64) (367.34) (1,121.29) (233.06)
(2,386.33)
in millions of $

EPS

Mar Jun Sep Dec Year
’26 2.10 (0.43) — —
—
’25 (0.07) (0.64) (1.38) (6.35)
(8.44)
’24 0.97 0.25 0.96 (0.38)
1.80
’23 0.44 0.51 0.13 (0.54)
0.54
’22 (0.96) 1.67 2.11 0.31
3.18
’21 0.04 2.61 0.67 0.47
3.82
’20 0.14 1.82 0.63 3.26
6.01

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

3.1
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 126.74 90.73 96.44 44.10 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 224.33 172.65 131.36 105.14 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 593 568 552 514 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.37 5.08 5.65 5.89 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,588.96 2,885.70 3,116.39 3,026.56 — — —
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 69.75% 70.23% 70.82% 69.52% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 132.78 2.98 374.36 (1,849.54) — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.13% 0.10% 12.01% (61.11%) — — —
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 670.70 280.99 510.73 (1,216.73) — — —
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 941.73 1,016.84 1,135.14 1,332.34 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 16.02 16.88 18.11 17.77 — — —
Revenue/Sh
‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 3.18 0.54 1.80 (8.44) — — —
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.01 9.54 8.74 8.30 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (32.11) (14.56) (8.43) 2.64 — — —
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (24.10) (5.02) 0.31 10.94 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 140.26 132.27 130.05 112.14 — — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 161.66 170.91 172.07 170.31 — — —
Shares
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 46.04 239.46 54.19 0.00 — — —
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.00 7.66 5.39 2.75 — — —
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.03 0.98 0.75 0.44 — — —
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 12.73 11.35 9.14 6.67 — — —
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (8.46) (38.19) 533.09 10.83 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,294.32 1,630.55 1,504.52 1,414.05 — — —
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (5,190.84) (2,488.30) (1,451.12) 449.95 — — —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (3,896.52) (857.75) 53.41 1,864.00 — — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1,605.67) (1,941.96) (2,088.09) (1,836.65) — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10,509.76 11,315.64 12,244.37 12,400.55 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9,651.79 10,654.87 11,684.52 11,846.80 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 22,673.63 22,606.51 22,378.49 19,097.65 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.56% 0.26% 0.83% (4.02%) — — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.21% 1.38% 1.53% 1.29% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.46% 0.41% 1.38% (6.93%) — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Alexandria Real Estate Equities (ARE), a premier REIT specializing in life science and tech campuses in hotspots like Boston and San Francisco, has powered through a decade of booms and busts with impressive 16% revenue CAGR from 2016-2024, fueled by pandemic-driven lab space demand. Yet, shares have cratered over 75% from 2021 peaks amid soaring interest rates, biotech funding droughts, and hybrid work pressures, trading at rock-bottom valuations like 2.8x PS and 0.4x PB as of early 2026—despite revenue still up 47% over that span.

Fundamentals show resilience: stable 70% gross margins, surging free cash flow to $1.86 billion in 2025 (from deep negatives), and capex shifting to maintenance mode as expansion cools. Earnings swing wildly, with a projected 2025 plunge to -$1.22 billion net loss from property impairments, exacerbated by debt doubling to $12.4 billion—but improving cash flows signal a deleveraging pivot and reduced financing needs.

Analysts eye modest 14% upside, betting on Fed rate cuts to shrink cap rates and revive biotech leasing, mirroring past REIT recoveries like Prologis post-GFC. Risks loom from office vacancies and further impairments, but at trough multiples in a secular life sciences tailwind, ARE offers 10-15% potential annualized returns for patient investors—dive into the full analysis for leasing catalysts and strategic parallels.

Read full commentary →

Alexandria Real Estate Equities, Inc. (ARE) Latest News

News by impact score

Fine-tune

6 Sep

3 , 9:55 AM
Alexandria Real Estate Equities (ARE) posts a profit rebound that is accompanied by cash flow challenges. Profit rebound offset by cash flow issues may influence short-term financial perception and market sentiment without fundamentally altering long-term trajectory.

26 Aug

3 , 2:18 AM
Alexandria Real Estate Equities (ARE) releases October results alongside a valuation split that separates asset classes and highlights differing multiples for lab and office holdings. October results and valuation split may shift near-term sentiment and segment multiples without altering core long-term trajectory.

4 Aug

3 transcript www.marketbeat.com, 4:04 PM
Alexandria Real Estate Equities, Inc. released Q2 earnings call highlights covering financial results, operational metrics and forward outlook. Q2 earnings metrics directly shape near-term investor views and trading in ARE shares.

3 Aug

3 , 5:45 PM
Alexandria Real Estate Equities beat Q2 estimates for FFO and revenues. Q2 earnings beat can lift near-term sentiment and valuation multiples.

29 Jul

3 , 8:30 AM
Alexandria Real Estate Equities reaches foundational milestone in mission-critical partnership with Foundation for the National Institutes of Health to advance precision medicine for depression. Partnership milestone may moderately boost life science real estate positioning and investor sentiment without major immediate financial shifts.

28 Jul

3 , 2:40 PM
Alexandria Real Estate Equities, Inc. (ARE) is set to release Q2 earnings, with analysis focusing on expected stock performance and market reactions to the results. Quarterly earnings releases typically generate moderate stock volatility depending on results versus forecasts.

22 Jul

4 , 3:10 AM
Alexandria Real Estate Equities delivers 427,000 RSF Bristol Myers Squibb R&D hub. Large-scale R&D facility delivery secures major long-term lease revenue and expands life-science portfolio footprint.

21 Jul

3 , 8:09 AM
Alexandria Real Estate Equities secured a $5b credit facility, indicating the stock may be 10% undervalued. The $5b credit move boosts liquidity and may support short-term valuation without major strategic shifts.

20 Jul

3 , 8:30 AM
Alexandria Real Estate Equities, Inc. completed delivery of a 427,000 RSF research and development hub for a multinational pharmaceutical company at the Campus Point by Alexandria Megacampus in San Diego. New R&D facility expands ARE's life sciences portfolio and secures long-term rental revenue from a major tenant.

10 Jul

3 www.barchart.com, 8:13 AM
Alexandria Real Estate Equities, Inc. prepares to report quarterly results with focus on revenue, occupancy rates, and development pipeline metrics that shape investor expectations ahead of the release. Earnings preview sets near-term expectations that can move ARE stock and influence short-term sentiment without altering long-term strategy.

27 May

3 Zacks, 11:30 AM
Alexandria Real Estate Equities (ARE) shares rose 20% since the last earnings report on strong life science property demand and favorable financial metrics. Post-earnings stock gains of 20% indicate moderately positive investor sentiment toward operational results without signaling major strategic shifts.

12 May

4 , 8:14 AM
Alexandria Real Estate Equities, Inc. (ARE), a life science REIT, cuts its dividend, challenging its valuation and income appeal to investors amid sector pressures. Dividend cut undermines ARE's high-yield REIT status, significantly impacting investor sentiment and stock valuation.

2 May

4 Simply Wall St., 11:13 PM
Alexandria Real Estate Equities (ARE) shares plunged 12.7% after reporting a swing to Q1 profitability despite lower revenue. Q1 profit swing on lower revenue triggered a sharp 12.7% stock drop, significantly impacting investor sentiment and near-term performance.

29 Apr

4 GuruFocus.com, 3:09 AM
Alexandria Real Estate Equities Inc. (ARE) Q1 2026 earnings call highlights navigating market challenges with key financial updates and strategic insights. Q1 2026 earnings highlights detail market navigation strategies poised to significantly influence ARE's financial performance and investor outlook.

28 Apr

4 www.marketbeat.com, 4:29 PM
Alexandria Real Estate Equities (ARE) Q1 earnings call highlights financial results, leasing activity, development updates, balance sheet strength, and positive outlook for life science real estate sector. Q1 earnings call highlights detail financial performance, guidance, and strategic updates that significantly influence ARE's valuation and market trajectory.

4 app.moby.co, 8:30 AM
Alexandria Real Estate Equities, Inc. (ARE) Q1 2026 earnings call summary highlights financial performance, leasing activity, development updates, and future outlook for the life science real estate sector. Q1 2026 earnings details, including revenue, NOI, guidance, and strategic updates, likely drive significant shifts in ARE's valuation and market positioning.

3 Insider Monkey, 9:28 PM
Alexandria Real Estate Equities (ARE) stock nears 17-year low amid bearish analyst outlook. Bearish analyst views push ARE stock toward 17-year low, moderately impacting market sentiment and financial performance perception.

3 Zacks, 10:58 AM
Alexandria Real Estate Equities (ARE) reported Q1 FFO matching analyst estimates, with revenues exceeding expectations due to strong tenant collections. Q1 FFO meeting estimates and revenues topping forecasts signals moderate positive influence on financial performance without transformative changes.

27 Apr

4 Zacks, 6:00 PM
Alexandria Real Estate Equities (ARE) Q1 earnings key metrics compared to analyst estimates, highlighting performance against expectations. Q1 earnings metrics versus estimates signal financial health and directly affect investor sentiment and stock trajectory.

4 PR Newswire, 4:10 PM
Alexandria Real Estate Equities, Inc. reported 1Q26 diluted net income per share of $2.10 and adjusted diluted FFO per share of $1.73. Quarterly earnings release with specific net income and FFO figures directly influences financial performance expectations and investor sentiment.

3 Zacks, 5:30 PM
Alexandria Real Estate Equities (ARE) met Q1 FFO estimates. Meeting Q1 FFO estimates affirms financial stability and supports moderate positive impact on market performance.

21 Apr

3 , 12:36 PM
Alexandria Real Estate Equities (ARE) prepares to report Q1 earnings, with analysts forecasting revenue of $675.8 million, FFO of $2.42 per share, and highlighting risks from high interest rates, office vacancies, and development delays amid life science sector challenges. Q1 earnings expectations could moderately affect ARE's financial performance and investor sentiment but are balanced by market headwinds.

28 Mar

3 Simply Wall St., 2:05 AM
Alexandria Real Estate Equities (ARE) valuation analyzed after removal from FTSE All World Index, highlighting potential impacts on stock performance and investor interest. Index removal triggers passive fund selling, moderately impacting short-term stock price and market sentiment without altering long-term fundamentals.

5 Mar

4 Simply Wall St., 5:13 PM
Alexandria Real Estate Equities (ARE) cuts dividend, raises debt, and sees major investors exit, questioning the viability of its investment case. Dividend cuts, debt increases, and investor exits erode confidence and heighten financial risks for ARE's trajectory.

3 Zacks, 12:05 PM
Alexandria Real Estate Equities (ARE) stock surged 19.2% over the past three months, raising questions about whether the upward momentum will persist. 19.2% stock rise in three months signals moderately positive momentum likely to influence investor sentiment without fundamentally altering long-term trajectory.

2 Mar

3 PR Newswire, 8:30 AM
Alexandria Real Estate Equities, Inc. declares cash dividend of $0.72 per common share for Q1 2026. Dividend declaration reinforces financial stability and appeals to income investors, moderately boosting short-term market sentiment without altering core strategy.

25 Feb

3 Zacks, 11:30 AM
Alexandria Real Estate Equities (ARE) shares dropped 7.6% since the last earnings report amid investor concerns over weaker-than-expected results, including missed EPS estimates, revenue shortfalls, and guidance disappointments. Post-earnings decline highlights investor dissatisfaction with financial performance, likely causing moderate short-term pressure on stock price and sentiment.

10 Feb

4 Simply Wall St., 8:11 PM
Alexandria Real Estate Equities, Inc. has successfully refinanced its long-term debt to optimize interest costs and extend maturities. This strategic move aims to enhance financial flexibility and reduce overall debt service expenses, positioning the company for improved operational efficiency and growth potential in the future. Refinancing long-term debt can significantly impact financial performance and investor sentiment by improving cash flow and reducing interest expenses.

3 PR Newswire, 6:56 PM
Alexandria Real Estate Equities, Inc. has announced the pricing of a public offering of $750,000,000 in senior notes due in 2036. The offering is expected to enhance the company's financial flexibility and support its growth initiatives. Proceeds from the offering will be used for general corporate purposes, including funding acquisitions and capital expenditures. The issuance of senior notes is likely to provide financial resources that could moderately influence the company's growth and operational capabilities.

3 PR Newswire, 12:22 PM
Alexandria Real Estate Equities, Inc. has announced the pricing terms for its cash tender offers for certain series of its outstanding notes. The offers are set to expire on a specified date, and the company aims to optimize its capital structure through these transactions. The tender offers are part of Alexandria's ongoing strategy to manage its debt and enhance financial flexibility. The cash tender offers may moderately influence the company's financial performance and capital structure.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us